CSPC Pharmaceutical Group (1093.HK) Earnings Analysis
CSPC Pharmaceutical Group (1093.HK) next reports earnings on 2026-08-26, consensus EPS 0.2707 HKD. It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 21.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1093.HK next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | 0.2707 HKD |
| Revenue estimate | 18.39B |
1093.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-19 | 0.2428 HKD | n/a | n/a | n/a |
| 2025-05-29 | 0.13 HKD | 0.12 HKD | +8.3% | Beat |
| 2024-11-15 | 0.2735 HKD | 0.11 HKD | +148.6% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
1093.HK valuation and analyst view
| Trailing P/E | 21.26 |
|---|---|
| Trailing EPS | 0.33082 HKD |
| Price / book | 2.51 |
| Dividend yield | 3.46% |
| Market cap | 95.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is CSPC Pharmaceutical Group (1093.HK)'s next earnings date?
CSPC Pharmaceutical Group is next scheduled to report on 2026-08-26, with a consensus EPS estimate of 0.2707 HKD and revenue estimate of 18.39B.
Did 1093.HK beat earnings last quarter?
Consensus estimate data was not available for 1093.HK's 2025-08-19 report.
What is 1093.HK's earnings track record?
Over the last 2 reported quarters with consensus data, 1093.HK beat estimates 2 times (100%).
What is 1093.HK's current P/E ratio and EPS?
1093.HK trades at a trailing P/E of 21.26 on trailing EPS of 0.3308205467824546 HKD.
What do analysts rate 1093.HK?
1093.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.